https://orcid.org/0009-0002-5881-2709
Dear Editor, we would like to share ideas on the publication “Factors associated with COVID-19 vaccination coverage in hypertensive patients with Omicron infection in Shanghai, China.”Citation1 The purpose of this study was to learn about the vaccination status and risk factors associated with non-vaccination in hypertensive patients with Omicron infection. It enrolled 4576 hypertensive patients with Omicron infection and discovered that 77.7% had at least one dose of vaccine and 45.0% had a booster dose. The study discovered that vaccinated status was associated with male gender, older age, diabetes mellitus, chronic pulmonary diseases, chronic kidney disease, and cancer. However, among hypertensive patients with Omicron infection, vaccine coverage was low, particularly for boosters. The study emphasizes the importance of targeted interventions to address under-vaccination in various hypertensive populations.
One potential limitation of the study is that it was limited to hypertensive patients with Omicron infection, which may limit the generalizability of the findings to a larger population. Furthermore, the study did not provide detailed reasons or barriers for hypertensive population under-vaccination, which could have provided valuable insights for developing targeted interventions. Concerns are raised every time a new COVID-19 vaccine is developed and made available to the public. If the peasants hear bad news, they may become terrified. The main source of concern is the potential impact of the COVID-19 vaccine on the general public.Citation2 The start date of the COVID-19 outbreak, as well as the surrounding conditions, influence resistance patterns.Citation3
Future research could investigate the specific barriers and reasons for low vaccine coverage rates among this group to address the under-vaccination of diverse hypertensive populations. Understanding the factors influencing under-vaccination can help inform the development of tailored strategies, such as targeted education campaigns, improved access to vaccination sites, and addressing vaccination concerns or misconceptions. Longitudinal studies could also be conducted to evaluate the long-term effectiveness and durability of vaccine protection in hypertensive patients, as well as the impact of booster doses on their immune response and overall health outcomes.
Consent for publication
Agree
Authors’ contribution
HD 50% ideas, writing, analyzing, approval.
VW 50% ideas, supervision, approval.
SW 1/2 ideas, writing, analyzing, approval for submission.
VW 1/2 ideas, supervision, approval for submission.
Disclosure statement
No potential conflict of interest was reported by the author(s).
Additional information
Funding
References
- Zhu K, Ma S, Chen H, Xie J, Huang D, Ma G, Huang Y. Factors associated with COVID-19 vaccination coverage in hypertensive patients with Omicron infection in Shanghai, China. Hum Vaccin Immunother. 2023 Aug;19(2):2253599. doi:10.1080/21645515.2023.2253599.
- Mungmunpuntipantip R, Wiwanitkit V. COVID-19 vaccination hesitancy. Recenti Prog Med. 2021 Sep;112(9):596. doi:10.1080/21645515.2022.2124090.
- Xiao J, Cheung JK, Wu P, Ni MY, Cowling BJ, Liao Q. Temporal changes in factors associated with COVID-19 vaccine hesitancy and uptake among adults in Hong Kong: serial cross-sectional surveys. Lancet Reg Health West Pac. 2022;23:100441. doi:10.1016/j.lanwpc.2022.100441.